323
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Multidrug-Resistant Infections Among Hospitalized Adults With Community-Acquired Pneumonia In An Indonesian Tertiary Referral Hospital

ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 3663-3675 | Published online: 25 Nov 2019

References

  • Anevlavis S, Bouros D. Community acquired bacterial pneumonia. Expert Opin Pharmacother. 2010;11(3):361–374.20085502
  • Eccles S, Pincus C, Higgins B, et al. Diagnosis and management of community and hospital acquired pneumonia in adults: summary of NICE guidance. BMJ. 2014;349:1–5.
  • Mandell LA, Wunderink RG, Anzueto A, et al. Infectious diseases society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–S72.17278083
  • Woodhead M. New guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2011;38(6):1250–1251.22130759
  • Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):iii1–iii55.19783532
  • Arnold FW, Wiemken TL, Peyrani P, Ramirez JA, Brock GN. Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the community-acquired pneumonia organization (CAPO) International cohort study. Respir Med. 2013;107(7):1101–1111.23660396
  • National report of basic health research (Laporan nasional Riskesdas 2018), Ministry of Health, Republic of Indonesia. 2018 Available from: http://labdata.litbang.depkes.go.id/riset-badan-litbangkes/menu-riskesnas/menu-riskesdas/426-rkd-2018 Accessed 912, 2019.
  • Ministry of Health, Republic of Indonesia, Basic health research (Riskesdas 2013). 2013 Available from: http://labdata.litbang.depkes.go.id/riset-badan-litbangkes/menu-riskesnas/menu-riskesdas/374-rkd-2013 Accessed 912, 2019.
  • File TM. Community-acquired pneumonia. Lancet (London, England). 2003;362(9400):1991–2001.
  • Rodrigo-Troyano A, Sibila O. The respiratory threat posed by multidrug resistant Gram-negative bacteria. Respirology. 2017;22(7):1288–1299.28681941
  • Padget M, Guillemot D, Delarocque-Astagneau E. Measuring antibiotic consumption in low-income countries: a systematic review and integrative approach. Int J Antimicrob Agents. 2016;48(1):27–32.27318624
  • World Health Organization. Antimicrobial resistance: global report on surveillance. 2014 Available from: https://apps.who.int/iris/bitstream/handle/10665/112642/9789241564748_eng.pdf. Accessed September 24, 2019.
  • de Kraker MEA, Wolkewitz M, Davey PG, et al. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother. 2011;66(2):398–407.21106563
  • de Kraker MEA, Davey PG, Grundmann H. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011;8(10):e1001104.22022233
  • van Hecke O, Wang K, Lee JJ, Roberts NW, Butler CC. Implications of antibiotic resistance for patients’ recovery from common infections in the community: a systematic review and meta-analysis. Clin Infect Dis. 2017;65(3):371–382.28369247
  • Ong CWM, Lye DCB, Khoo KL, et al. Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific. Respirology. 2009;14(8):1200–1205.19909464
  • Mohd R, Nesam T, Kamaruzaman L, Cader RA, Mustafar R, Kong W-Y. Community acquired multi drug resistant (MDR) Acinetobacter baumannii pneumonia in Malaysia - A case report. Respir Med Case Rep. 2018;24:147–149.29977783
  • Peng C, Zong Z, Fan H. Acinetobacter baumannii isolates associated with community-acquired pneumonia in West China. Clin Microbiol Infect. 2012;18(12):E491–3.23057470
  • Ethical principles for medical research involving human subjects version 2013. 64th World Medical Association General Assembly, Fortaleza, Brazil, October 2013 Available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ Accessed 711, 2019.
  • Adapted from Indonesian Society of Respirology. Guideline for diagnosis and man-agement of community pneumonia in Indonesia[Perhimpunan Dokter Paru Indonesia. Pneumonia komuniti: pedoman diagnosis & penatalaksanaan di Indonesia] 2003, page 13. Available from: http://www.klikpdpi.com/konsensus/konsensus-pneumoniakom/pnkomuniti.pdf Accessed October 7, 2019.
  • Roson B, Carratala J, Verdaguer R, Dorca J, Manresa F, Gudiol F. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis. 2000;31(4):869–874.11049763
  • Magiorakos A-P, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281.21793988
  • Clinical and Laboratory Standards Institute. Available from: https://clsi.org/ Accessed 524, 2019
  • Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250.8995086
  • Holter JC, Ueland T, Jenum PA, et al. Risk factors for long-term mortality after hospitalization for community-acquired pneumonia: a 5-year prospective follow-up study. PLoS One. 2016;11(2):e0148741.26849359
  • Luna CM, Palma I, Niederman MS, et al. The impact of age and comorbidities on the mortality of patients of different age groups admitted with community-acquired pneumonia. Ann Am Thorac Soc. 2016;13(9):1519–1526.27398827
  • Harris AM, Bramley AM, Jain S, et al. Influence of antibiotics on the detection of bacteria by culture-based and culture-independent diagnostic tests in patients hospitalized with community-acquired pneumonia. Open Forum Infect Dis. 2017;4(1). DOI:10.1093/OFID/OFX014
  • Miyashita N, Shimizu H, Ouchi K, et al. Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization. Med Sci Monit. 2008;14(4):CR171–6.18376343
  • Hung IF-N, Tantawichien T, Tsai YH, Patil S, Zotomayor R. Regional epidemiology of invasive pneumococcal disease in Asian adults: epidemiology, disease burden, serotype distribution, and antimicrobial resistance patterns and prevention. Int J Infect Dis. 2013;17(6):e364–73.23416209
  • Peto L, Nadjm B, Horby P, et al. The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review. Trans R Soc Trop Med Hyg. 2014;108(6):326–337.24781376
  • Goyet S, Vlieghe E, Kumar V, et al. Etiologies and resistance profiles of bacterial community-acquired pneumonia in Cambodian and neighboring countries’ health care settings: a systematic review (1995 to 2012). PLoS One. 2014;9(3):e89637.24626053
  • Ergin A, Köseog Ö. Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases. New Microbiol. 2011;34:187–193.21617831
  • Hakenbeck R, Brückner R, Denapaite D, Maurer P. Molecular mechanisms of b -lactam resistance in Streptococcus pneumoniae. Future Microbiology 2012;7(3)395–410. doi:10.2217/fmb.12.2
  • Cornick JE, Bentley SD. Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides. Microbes Infect. 2012;14(7–8):573–583.22342898
  • Stinson MW, Alder S, Kumar S. Invasion and killing of human endothelial cells by viridans group streptococci. Infect Immun. 2003;71(5):2365–2372.12704106
  • Bochud PY, Calandra T, Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med. 1994;97(3):256–264.8092175
  • Choi SH, Cha S-I, Choi K-J, et al. Clinical characteristics of community-acquired viridans streptococcal pneumonia. Tuberc Respir Dis (Seoul). 2015;78(3):196–202.26175772
  • Shinzato T, Saito A. The Streptococcus milleri group as a cause of pulmonary infections. Clin Infect Dis. 1995;21(Suppl 3):S238–43.8749672
  • Waitkins SA, Ratcliffe JG, Roberts C. Streptococcus milleri found in pulmonary empyemas and abscesses. J Clin Pathol. 1985;38(6):716–717.
  • Shore AC, Deasy EC, Slickers P, et al. Detection of staphylococcal cassette chromosome mec type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2011;55(8):3765–3773.21636525
  • Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza–louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep. 2007;56(14):325–329.17431376
  • Farida H, Gasem MH, Suryanto A, et al. Viruses and Gram-negative bacilli dominate the etiology of community-acquired pneumonia in Indonesia, a cohort study. Int J Infect Dis. 2015;38:101–107.26255889
  • Krisanapan S, Naphathorn P, Kaewprom P. Community acquired Acinetobacter pneumonia: report of two cases. Southeast Asian J Trop Med Public Health. 1989;20(3):497–498.2633358
  • Allen DM, Hartman BJ. Acinetobacter species In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Disease. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005 p. 2632.
  • Hujer KM, Hujer AM, Hulten EA, et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the walter reed army medical center. Antimicrob Agents Chemother. 2006;50(12):4114–4123.17000742
  • Kuntaman K, Lestari ES, Severin JA, et al. Fluoroquinolone-resistant Escherichia coli, Indonesia. Emerg Infect Dis. 2005;11(9):1363–1369.16229763
  • Song JH, Oh WS, Kang CI, et al. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int J Antimicrob Agents. 2008;31(2):107–114.18162378
  • Farida H, Severin JA, Gasem MH, et al. Nasopharyngeal carriage of Klebsiella pneumoniae and other Gram-negative bacilli in pneumonia-prone age groups in Semarang, Indonesia. J Clin Microbiol. 2013;51(5):1614–1616.23486716
  • Hyllienmark P, Martling C-R, Struwe J, Petersson J. Pathogens in the lower respiratory tract of intensive care unit patients: impact of duration of hospital care and mechanical ventilation. Scand J Infect Dis. 2012;44(6):444–452.22324935
  • Papan C, Meyer-Buehn M, Laniado G, Nicolai T, Griese M, Huebner J. Assessment of the multiplex PCR-based assay Unyvero pneumonia application for detection of bacterial pathogens and antibiotic resistance genes in children and neonates. Infection. 2018;46(2):189–196.29086343
  • Verhamme KMC, De Coster W, De Roo L, et al. Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia. Infect Control Hosp Epidemiol. 2007;28(4):389–397.17385143
  • Iroezindu MO, Chima EI, Isiguzo GC, et al. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study. Scand J Infect Dis. 2014;46(12):875–887.25288384
  • Resistance D. Community acquired pneumonia among adult patients at an Egyptian university hospital : bacterial etiology, susceptibility profile and evaluation of the response to initial empiric antibiotic therapy. infect Drug Resist. 2018;11:2141–2150.
  • Bruns AHW, Oosterheert JJ, Cucciolillo MC, et al. Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population. Clin Microbiol Infect. 2011;17(5):763–768.20807226
  • Ramirez JA, Srinath L, Ahkee S, Huang A, Raff MJ. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. Arch Intern Med. 1995;155(12):1273–1276.7778957
  • Eckburg PB, Friedland HD, Llorens L, et al. Day 4 clinical response of Ceftaroline Fosamil Versus Ceftriaxone for community-acquired bacterial Pneumonia. Infect Dis Clin Pract. 2012;20(4):254–260.